Back

Personalised care for hyperlipidaemia by tailoring shared decision-making toward patient priorities & needs: results from a patient-led study

2 September 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Patient-centred care: digital health interventions and treatment preferences Patient Engagement and Personalised Health ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Neil Johnson

Global Heart Hub, Galway (Ireland)

8 More presentations in this session

Presentation thumbnail
Effect of remote monitoring on the management of heart failure patients with cardiac amyloidosis
Professor M. Seronde (Besancon, FR)
Abstract Slides Video
Presentation thumbnail
"I don't want hear about that": Treatment wishes/preferences of elderly patients regarding possible treatment goals in acute life-threatening illness or acute organ failure
Mrs S. Richter (Gera, DE)
Abstract Slides Video
Presentation thumbnail
Effect of participant baseline characteristics on adherence to self-monitoring of diet, physical activity and weight in a 12-month weight loss mHealth trial
Professor L. Burke (Pittsburgh, US)
Abstract Slides Video
Presentation thumbnail
Feasibility and end-user perceptions of a novel digital care assistant and support program for people after stroke or transient ischemic attack (CAPS)
Mr L. Allan (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Engagement of adults with congenital heart disease in research: overcoming barriers relating to social deprivation
Doctor A. Constantine (Birmingham, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Patient-centred care: digital health interventions and treatment preferences

The Event

Event poster

ESC Congress 2024

2 September 2024 14:00 CET
You may be interested in
thumbnail
Congress Session
Dyslipidaemia management: a cornerstone in cardiovascular multimorbid patients’ care
thumbnail
Congress Presentation
Personalised lipid-lowering therapy in different patient populations
thumbnail
Congress Session
Changing face of lipid-lowering therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources